期刊
ANALYTICAL CHEMISTRY
卷 92, 期 17, 页码 11981-11986出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.0c02430
关键词
-
资金
- Shenzhen Science and Technology Program [KQJSCX20180328165437711, KQTD20170810105439418]
- National Natural Science Foundation of China [81973280, 81773680]
- Innovative team and talent training project of Shihezi [2018TD02]
- key technique improvement of Xinjiang Licorice planting and quality control of Xinjiang Production & Construction Corps [2018AB012]
Rapid yet accurate detection of disease-related biomarkers is key for point of care testing, where there is an increasing demand for multi-index analysis. Here, we present a versatile device for multianalyte quantification based on the microfluidic technique and electrochemical sensor array. The analytes were shunted through inner-built channels to screen-printed electrodes installed at different positions of the chip. These electrodes were modified with different nanomaterials and sensing agents to afford specific responses to the corresponding indicators. To prove the applicability of the platform for multifunction, we chose leukemia as the model disease and determined four relevant markers: methotrexate (MTX), lactate dehydrogenase (LDH), uric acid (UA), and urea. They are indicative as/for the therapeutic drug (MTX), prognosis (LDH), and side effect (UA and urea). The sensing chip exhibited low detection limits of 35 nM, 25 U/L, 450 nM, and 20 mu M toward the four analytes, which are much lower than their minimum contents in human serum. Furthermore, practical application of the chip was demonstrated by simultaneous detection of the four analytes in the blood plasma of rabbit. By simply replacing the modification agents, the sensing platform is expected to serve the detection of a wide range of them/ biosubstances in various fields.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据